Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 39 | $6,399,416 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 14 Nov 2024 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 12 Nov 2024 | Sale | 15,000 | 7.6419 | 114,628 | D |
| 14 Nov 2024 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Nov 2024 | Sale | 15,000 | 7.6584 | 114,876 | D |
| 10 Oct 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 08 Oct 2024 | Sale | 15,000 | 6.3171 | 94,756 | D |
| 10 Oct 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 09 Oct 2024 | Sale | 15,000 | 6.3583 | 95,374 | D |
| 12 Sep 2024 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 11 Sep 2024 | Sale | 15,000 | 6.3153 | 94,730 | D |
| 12 Sep 2024 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 10 Sep 2024 | Sale | 15,000 | 6.1666 | 92,499 | D |
| 15 Aug 2024 17:24 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Aug 2024 | Sale | 15,000 | 6.3501 | 95,252 | D |
| 15 Aug 2024 17:24 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Aug 2024 | Sale | 15,000 | 6.3455 | 95,182 | D |
| 11 Jul 2024 16:51 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 09 Jul 2024 | Sale | 15,000 | 7.3185 | 109,778 | D |
| 11 Jul 2024 16:51 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 10 Jul 2024 | Sale | 15,000 | 7.2384 | 108,576 | D |
| 17 Jun 2024 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Jun 2024 | Sale | 15,000 | 9.2721 | 139,082 | D |
| 17 Jun 2024 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Jun 2024 | Sale | 15,000 | 9.3199 | 139,798 | D |
| 18 Apr 2024 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 17 Apr 2024 | Sale | 23,124 | 7.583 | 175,349 | D |
| 18 Apr 2024 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Apr 2024 | Sale | 25,000 | 7.6663 | 191,658 | D |
| 14 Mar 2024 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Mar 2024 | Sale | 25,000 | 11.0326 | 275,815 | D |
| 14 Mar 2024 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 12 Mar 2024 | Sale | 25,000 | 10.455 | 261,375 | D |
| 15 Feb 2024 18:00 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Feb 2024 | Sale | 1,067 | 10.9841 | 11,720 | D |
| 15 Feb 2024 18:00 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Feb 2024 | Sale | 23,933 | 10.4335 | 249,705 | D |
| 15 Feb 2024 18:00 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Feb 2024 | Sale | 25,000 | 9.8624 | 246,560 | D |
| 18 Jan 2024 18:37 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 17 Jan 2024 | Sale | 25,000 | 10.2539 | 256,348 | D |
| 18 Jan 2024 18:37 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Jan 2024 | Sale | 25,000 | 10.4464 | 261,160 | D |
| 14 Dec 2023 18:53 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Dec 2023 | Sale | 25,000 | 7.5908 | 189,770 | D |
| 14 Dec 2023 18:53 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 12 Dec 2023 | Sale | 25,000 | 7.3947 | 184,868 | D |
| 16 Nov 2023 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 15 Nov 2023 | Sale | 4,700 | 7.6168 | 35,799 | D |
| 16 Nov 2023 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 15 Nov 2023 | Sale | 20,300 | 7.2506 | 147,187 | D |
| 16 Nov 2023 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Nov 2023 | Sale | 25,000 | 6.3177 | 157,942 | D |
| 12 Oct 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 11 Oct 2023 | Sale | 25,000 | 6.8525 | 171,312 | D |
| 12 Oct 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 10 Oct 2023 | Sale | 25,000 | 7.0705 | 176,762 | D |
| 14 Sep 2023 18:26 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Sep 2023 | Sale | 25,000 | 8.6927 | 217,318 | D |
| 14 Sep 2023 18:26 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 12 Sep 2023 | Sale | 25,000 | 8.4253 | 210,632 | D |
| 17 Aug 2023 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Aug 2023 | Sale | 25,000 | 8.9007 | 222,518 | D |
| 17 Aug 2023 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 15 Aug 2023 | Sale | 25,000 | 9.2717 | 231,792 | D |
| 19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 19 Jul 2023 | Sale | 9,859 | 15.999 | 157,734 | D |
| 19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 19 Jul 2023 | Sale | 13,150 | 15.3626 | 202,018 | D |
| 19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 19 Jul 2023 | Sale | 1,991 | 14.3626 | 28,596 | D |
| 19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 18 Jul 2023 | Sale | 500 | 14.048 | 7,024 | D |
| 19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 18 Jul 2023 | Sale | 24,500 | 13.6236 | 333,778 | D |
| 15 Jun 2023 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Jun 2023 | Sale | 25,000 | 10.0735 | 251,837 | D |
| 15 Jun 2023 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Jun 2023 | Sale | 25,000 | 9.9323 | 248,308 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)